Clinical Trial Update: A Study of the Efficacy and Safety of KUS121 in Participants With Acute Non-Arteritic Central Retinal Artery Occlusion (CRAO) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the efficacy and safety of KUS121 for acute non-arteritic central retinal artery occlusion has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Retinal Artery Occlusion

Drugs mentioned

• KUS121

Snippet

Sponsor: Kyoto Drug Discovery and Development Co., Ltd. | Conditions: Central Retinal Artery Occlusion | Phase 2 | Status: COMPLETED